Impact of proactive of infliximab monitoring using the Bayesian approach in the maintenance phase in patients with inflammatory bowel disease

  1. Díaz, L.S.
  2. Navalón, C.I.
  3. Espín, R.G.
  4. Prado, I.N.D.
  5. Redondo, L.R.
Aldizkaria:
Gastroenterologia y Hepatologia

ISSN: 1578-9519 0210-5705

Argitalpen urtea: 2023

Alea: 46

Zenbakia: 7

Orrialdeak: 504-511

Mota: Artikulua

DOI: 10.1016/J.GASTROHEP.2022.10.019 GOOGLE SCHOLAR